Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
AstraZeneca agrees to offer US discounts in exchange for no tariffs
02:55am, Monday, 13'th Oct 2025
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has become the second giant drugmaker to announce a drug pricing deal with the US government, after Pfizer's deal two weeks ago. Pascal Soriot, the CEO of the
Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
09:25am, Sunday, 12'th Oct 2025
AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of Americans.
Trump announces drug-pricing deal with pharma giant
07:30pm, Friday, 10'th Oct 2025
President Trump details a new drug-pricing deal with AstraZeneca, and Fox News political analyst Lisa Boothe reacts on 'The Evening Edit.'
Trump reaches deal with AstraZeneca to lower U.S. drug prices
06:30pm, Friday, 10'th Oct 2025
The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S. The deal with AstraZeneca follows a simi
Pres. Trump announces deal with AstraZeneca to lower U.S. drug prices
06:17pm, Friday, 10'th Oct 2025
CNBC's Bertha Coombs details the Trump administration and AstraZeneca's agreement for the U.K.-based pharmaceutical giant to cut drug prices in the United States.
TrumpRx makes more drug pricing moves and strikes a deal with AstraZeneca
06:05pm, Friday, 10'th Oct 2025
Trump announces AstraZeneca deal for lower drug prices on TrumpRx.com platform. AstraZeneca, a UK-based firm, said it will offer discounts on its prescription drug catalog.
Trump says AstraZeneca to offer drugs to US at discounted prices
05:54pm, Friday, 10'th Oct 2025
U.S. President Donald Trump announced an agreement with AstraZeneca on Friday where the drugmaker will offer its catalog of prescription drugs to the United States at a discounted price.
The agreement follows last week's deal with Pfizer.
AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market.
03:45pm, Friday, 10'th Oct 2025
AstraZeneca PLC looks poised to announce a deal with U.S. President Donald Trump that's focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfize
Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports
02:53pm, Friday, 10'th Oct 2025
The Trump administration and AstraZeneca have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S., MSNBC reported. President Donald Trump has already agreed to
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
10:15am, Friday, 10'th Oct 2025
Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to lower drug prices
AstraZeneca breaks ground at $4.5 billion Virginia plant as drugmakers court Trump
12:32pm, Thursday, 09'th Oct 2025
AstraZeneca broke ground on a new plant in Virginia on Thursday and said it would spend $4.5 billion on the facility as drugmakers look to respond to President Donald Trump's call for more medicines t
AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs
12:30pm, Thursday, 09'th Oct 2025
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces that it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500m to support the enhanced manu
Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery
06:00am, Thursday, 09'th Oct 2025
LONDON, UK and BUDAPEST, HUNGARY , Oct. 9, 2025 /PRNewswire/ -- Turbine, a leading company specializing in virtualizing biological experiments with AI, today announced a collaboration with AstraZeneca
AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study
12:15pm, Wednesday, 08'th Oct 2025
AZN's baxdrostat hit the main goal in the phase III Bax24 study, showing significant blood pressure reductions in patients with resistant hypertension.
